Skip to content

The impact of COVID-19 on colorectal cancer in regional Northern Queensland and changes to treatment related to distance to care

The impact of COVID-19 on colorectal cancer in regional Northern Queensland and changes to treatment related to distance to care

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12624000396527
Enrollment
500
Registered
2024-04-03
Start date
2022-08-17
Completion date
2023-01-31
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The COVID-19 pandemic has created challenges in the diagnosis and management of colorectal cancer (CRC). It was proposed in regional North Queensland the distance to services could further impact cancer outcomes, leading to delayed diagnosis. We compared the outcomes of patients prior and during the pandemic; with a focus on whether patients were presenting in the emergency setting with more advanced disease (i.e.T4 tumours, locally advanced cancers or stage III/IV CRC). The distance to treatment was also analysed to see if any impact occurred to the management of patients with colorectal cancer.

Interventions

Patients being treated with colorectal cancer will be assessed during the COVID 19 pandemic to assess if there has been increased emergency presentations and other changes to their treatment profile There will be no direct patient contact, a retrospective review of patient charts will be undertaken Observation would be for that current time perioud between March 2019 - July 2022

Sponsors

Richard Maguire
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion criteria: all patients that were diagnosed or treated for colorectal cancer during the time periods being analysed and definitively managed at the Townsville University Hospital

Exclusion criteria

Exclusion criteria: patients treated for benign pathology and for non colonic/rectal adenocarcinoma i.e. anal scc

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026